日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial

三氟尿苷-替吡嘧啶治疗既往接受过治疗的雌激素受体阳性、HER2阴性转移性乳腺癌患者(BOOG 2019-01 TIBET试验):一项单臂、多中心、II期试验

Guchelaar, Niels A D; Mathijssen, Ron H J; de Boer, Maaike; van Bekkum, Marlies L; Heijns, Joan B; Vriens, Birgit E P J; van Rosmalen, Mandy M; Kessels, Lonneke W; Hamming, Lisanne; Beelen, Karin J; Nieboer, Peter; van den Berg, Susan M; Hoop, Esther Oomen-de; Bijlsma, Rhodé M; Bos, Monique E M M

Early prediction of menopausal status after chemotherapy in women with early breast cancer in order to optimize adjuvant endocrine therapy

早期预测早期乳腺癌患者化疗后的绝经状态,以优化辅助内分泌治疗

van Zwol-Janssens, Charissa; van Rosmalen, Mandy M; Oomen-de Hoop, Esther; Drooger, Jan C; van der Padt-Pruijsten, Annemieke; Zuetenhorst, Hanneke J M; Louwers, Yvonne V; Visser, Jenny A; Laven, Joop S E; Jager, Agnes

Motion based ex vivo (MOTEX) culture of breast tumor slices sustains microenvironment composition.

基于运动的离体(MOTEX)乳腺肿瘤切片培养可维持微环境组成

Komar Zofia M, Bavelaar Mieke, Kageler Ellen, Verkaik Nicole S, van Rosmalen Mandy M, van Deurzen Carolien H M, den Bakker Michael A, Kanaar Roland, Houtsmuller Adriaan B, van den Bosch Thierry P P, Jager Agnes, van Gent Dik C